Corpus Intelligence IC Memo — CORYELL MEMORIAL HOSPITAL 2026-04-26 05:03 UTC
IC Memo — CORYELL MEMORIAL HOSPITAL
Investment Committee Memorandum | TX | 25 beds | Grade B | EBITDA uplift $22.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CORYELL MEMORIAL HOSPITAL

CCN 451379 | CORYELL, TX | 25 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

CORYELL MEMORIAL HOSPITAL is a 25-bed suburban community hospital in CORYELL, TX with $305.9M in net patient revenue and a -1.5% operating margin. The hospital serves a payer mix of 28.2% Medicare, 4.5% Medicaid, and 67.3% commercial.

Thesis: Turnaround. Our ML models identify $22.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.5% to 5.8% (+736bps).

Net Revenue HCRIS$305.9M
Current EBITDA COMPUTED$-4.7M
Operating Margin COMPUTED-1.5%
Occupancy HCRIS36.3%
Revenue / Bed COMPUTED$12.2M
Net-to-Gross HCRIS73.2%
Distress Probability ML39.9%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
256
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -1.5% places it below the state median. Among 256 size-comparable peers (12-50 beds), the median margin is -7.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 256 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CORYELL MEMORIAL HOSPITAL (Target)TX25$305.9M-1.5%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%
TEXAS SPINE AND JOINT HOSPITALTX20$147.3M30.3%
NORTH CENTRAL SURGICAL HOSPITATX24$143.6M32.0%
SCOTT AND WHITE HOSPITAL TAYLOTX25$139.7M-47.5%
BAYLOR SURGICAL HOSPITAL AT FOTX30$136.0M14.8%
BAYLOR SCOTT & WHITE - MARBLE TX46$135.1M-17.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $22.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.4M+210bp18mo
Cost to Collect4.5%2.5%$6.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.7M+122bp9mo
Clean Claim Rate88.0%96.0%$196K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.4M
Cost to Collect
$6.1M
Denial Rate Reduction
$6.1M
A/R Days Reduction
$3.7M
Clean Claim Rate
$196K
Total EBITDA Uplift$22.5M
Current EBITDA$-4.7M
+ RCM Uplift+$22.5M
Pro Forma EBITDA$17.9M
Current Margin-1.5%
Pro Forma Margin5.8%
WC Released (1x)$11.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-7.2M$194.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-7.2M$211.5M0.00x-100.0%
Bull Case9.0x11.0x$-6.5M$283.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.5M$307.4M0.00x-100.0%
Bear Case11.0x10.0x$-7.9M$84.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-7.9M$90.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 256 hospitals with 12-50 beds
  • Same-state prioritization (n=257)
  • Comp margins: P25=-36.8% / P50=-7.9% / P75=9.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.